Science Vs Fauci on Monkeypox: What Went Wrong
Aug 3, 2022
In a candid discussion, Dr. Anthony Fauci, the Chief Medical Advisor to the U.S. President and a leading infectious disease expert, delves into the slow response to the monkeypox outbreak. He highlights the logistical complexities of vaccine distribution and the stigma faced by affected communities, drawing parallels to early HIV struggles. Fauci emphasizes the urgency of preventing the virus from becoming endemic and the critical need for equitable access to vaccines and treatments. His insights shed light on improving future public health responses.
AI Snips
Chapters
Transcript
Episode notes
Early Monkeypox Concerns
- Dr. Fauci's initial reaction to the monkeypox outbreak was concern due to its efficient spread, reminiscent of early HIV.
- The circumstances surrounding the outbreak, particularly its occurrence in celebratory areas with multiple sexual partners, raised alarm bells.
Monkeypox vs. COVID-19
- Unlike COVID-19, monkeypox presented a different challenge, as existing countermeasures were available.
- The US had stockpiled smallpox vaccines (ACAM2000 and JYNNEOS) and a drug (TPOXX), making it an implementation issue rather than a development one.
Vaccine Challenges
- The US had ample ACAM2000 doses, but it was not ideal for vulnerable populations like those with HIV, who were significantly represented in the monkeypox outbreak.
- JYNNEOS, the safer alternative, was in limited supply, creating a logistical challenge.